Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 70/100

NeuroOne to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

Wednesday, February 5, 2025 2 min read
Key Takeaway: NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is set to announce its financial results for the first quarter of fiscal year 2025 on February 12, 2025. The company specializes in developing minimally invasive solutions for various neurological disorders. In addition to the financial results, management will host a conference call to provide a corporate update and address questions from investors. This event aims to enhance transparency and communication with stakeholders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Upcoming financial results may indicate improved fiscal health.
  • Company focuses on innovative solutions for neurological disorders.
  • Investor conference call provides opportunity for engagement.

Full Press Release Details

EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will release financial results for its fiscal first quarter ended December 31, 2024, before market open on February 12, 2025.
Management will host an investor conference call and webcast at 8:30 a.m. eastern time on Wednesday, February 12, 2025, to discuss the Company’s first quarter 2025 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information:
First Quarter and Fiscal 2025 Earnings Conference Call
Date: Wednesday, February 12, 2025
Time: 8:30 a.m. Eastern time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Participant Access Code: 234314
Webcast: https://www.webcaster4.com/Webcast/Page/2821/52002
Please join at least five minutes before the start of the call to ensure timely participation.
A playback of the call will be available through Wednesday, February 26, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 51728. A webcast replay will also be available using the webcast link above through February 13, 2025.
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit www.nmtc1.com.
MZ Group – MZ North America

Tags

NeuroOne Medical Technologies
medical technology company

Frequently Asked Questions

When will NeuroOne release its first quarter financial results?

NeuroOne will release its fiscal first quarter results on February 12, 2025.

What time is the NeuroOne investor conference call?

The investor conference call is scheduled for 8:30 a.m. Eastern time on February 12.

How can I access the NeuroOne conference call?

Call 888-506-0062 in the U.S. or 973-528-0011 internationally for access.

What technologies does NeuroOne focus on?

NeuroOne develops EEG recording, brain stimulation, and ablation solutions.

What conditions does NeuroOne target with its technologies?

NeuroOne targets epilepsy, Parkinson's, chronic pain, and other neurological disorders.

Tags: NMTC Viatris Investor Conferences Healthcare NeuroOne financial results investor call medical technology
Last updated: Feb 5, 2025